Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...

To determine the proportion of uveal melanoma patients who accept cytogenetic prognostication and to understand the reasons for their decision and the psychological impact of an adverse prognosis.

The presence of cytogenetic abnormalities at diagnosis has long proven to be one of the most important prognostic factors for AML. Furthermore, the sensitive technology and methods needed for ...

Recent published studies have demonstrated the incremental value of the use of cell-free DNA for noninvasive prenatal testing with 100% sensitivity for trisomies 21 and 18 and a specificity of ≥99.7% ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

Neuberg Sehgal Path Lab, a leading name in diagnostic services, has announces the launch of cutting-edge cytogenetics testing technology at its facilities in Mumbai. This advanced diagnostic tool is ...

The Cancer Cytogenetics Laboratory at the University Health Network (Toronto) started a pilot program nearly one year ago to test the feasibility of replacing karyotyping and FISH assays with Optical ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Molecular Cytogenetics Market - Forecast to 2021" report to their offering. The molecular cytogenetics market is ...

Neuberg Sehgal Path Lab, a leading name in diagnostic services, launched a cutting-edge cytogenetics testing technology at its facilities in Mumbai. This advanced diagnostic tool is poised to ...